BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9326221)

  • 1. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines.
    Ailles LE; Gerhard B; Hogge DE
    Blood; 1997 Oct; 90(7):2555-64. PubMed ID: 9326221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor.
    Hogge DE; Lansdorp PM; Reid D; Gerhard B; Eaves CJ
    Blood; 1996 Nov; 88(10):3765-73. PubMed ID: 8916940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML).
    Guan Y; Hogge DE
    Leukemia; 2000 Dec; 14(12):2135-41. PubMed ID: 11187903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.
    Petzer AL; Hogge DE; Landsdorp PM; Reid DS; Eaves CJ
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1470-4. PubMed ID: 8643656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
    Ailles LE; Humphries RK; Thomas TE; Hogge DE
    Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
    Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
    Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia.
    Petzer AL; Eaves CJ; Barnett MJ; Eaves AC
    Blood; 1997 Jul; 90(1):64-9. PubMed ID: 9207439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).
    Guan Y; Gerhard B; Hogge DE
    Blood; 2003 Apr; 101(8):3142-9. PubMed ID: 12468427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
    Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
    Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
    Udomsakdi C; Eaves CJ; Swolin B; Reid DS; Barnett MJ; Eaves AC
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6192-6. PubMed ID: 1631107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
    Ailles LE; Gerhard B; Kawagoe H; Hogge DE
    Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative mechanisms with and without steel factor support primitive human hematopoiesis.
    Sutherland HJ; Hogge DE; Cook D; Eaves CJ
    Blood; 1993 Mar; 81(6):1465-70. PubMed ID: 7680918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro.
    Ponchio L; Conneally E; Eaves C
    Blood; 1995 Nov; 86(9):3314-21. PubMed ID: 7579433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
    Feuring-Buske M; Frankel A; Gerhard B; Hogge D
    Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells.
    Gupta P; McCarthy JB; Verfaillie CM
    Blood; 1996 Apr; 87(8):3229-36. PubMed ID: 8605338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
    Petzer AL; Zandstra PW; Piret JM; Eaves CJ
    J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia.
    Guan Y; Ralph S; Hogge DE
    Exp Hematol; 2002 Jul; 30(7):721-8. PubMed ID: 12135669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.